FGF7 and pulmonary fibrosis: miR-155 inhibits at least two targets: (1) the mRNA encoding liver X receptor (LXRα), whose signaling exacerbates lung fibrosis [76], and (2) the mRNA encoding keratinocyte growth factor (KGF), which is primarily involved in the EMT response [77].